Christian E. Elling heads the early stage biotech investment unit Lundbeckfonden Emerge. He is a member of the board of directors of IO Biotech, NMD Pharma, Afyx Therapeutics, SNIPR Biome, Folium and former member of the board of directors of EpiTherapeutics and Inagen.
Christian was previously co-founder, Vice President of Biology and Development and later CEO of 7TM Pharma. Christian received his early training in biochemistry and received his PhD in pharmacology from University of Copenhagen, Denmark.
Direct +45 3912 8090